A combined phase 2a/b study of the efficacy, safety, and tolerability of repeated topical doses of regorafenib eye drops in treatment-naïve patients with neovascular age-related macular degeneration (nAMD) - Joussen, A M; Wolf, S; Kaiser, P K; Boyer, D S (Invest Ophthalmol Vis Sci, 2016)